K-877
Sponsors
Kowa Research Institute, Inc., Kowa Company, Ltd.
Conditions
DyslipidemiaHealthyNon-Alcoholic Fatty Liver DiseaseSevere HypertriglyceridemiaType2 Diabetes
Phase 1
Drug-Drug Interaction Study in Health Adult Volunteers
CompletedNCT02273986
Start: 2014-08-31Updated: 2014-10-24
Drug-Drug Interaction Study in Healthy Adult Volunteers
CompletedNCT02275975
Start: 2014-07-31Updated: 2014-10-27
Drug-Drug Interaction Study in Healthy Adult Volunteers
CompletedNCT02275988
Start: 2014-06-30Updated: 2014-10-27
Drug-Drug Interaction Study in Healthy Adult Volunteers
CompletedNCT02276001
Start: 2014-06-30Updated: 2014-10-27
Drug-Drug Interaction Study in Healthy Adult Volunteers
CompletedNCT02275962
Start: 2014-09-30End: 2015-05-31Updated: 2016-02-01
Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers
CompletedNCT02719431
Start: 2016-01-31End: 2016-02-29Updated: 2016-03-25
Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers
CompletedNCT02922465
Start: 2016-09-30End: 2016-11-30Updated: 2016-12-21
Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers
CompletedNCT04237597
Start: 2019-12-17End: 2020-03-04Updated: 2020-09-22
Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers
CompletedNCT04742218
Start: 2021-01-13End: 2021-04-11Updated: 2021-08-09
Phase 2
Phase 3
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
CompletedNCT03001817
Start: 2016-11-28End: 2019-06-24Updated: 2022-11-30
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
CompletedNCT03011450
Start: 2016-11-26End: 2019-07-05Updated: 2022-10-28
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
TerminatedNCT03071692
Start: 2017-03-23End: 2022-07-27Updated: 2025-09-25